Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.530
-0.050 (-1.94%)
At close: Oct 9, 2026, 4:00 PM EDT
2.560
+0.030 (1.19%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $57.55 million as of October 9, 2026. It is the 29,415th most valuable company in the world and the 4,563rd biggest in the United States. Its market cap has increased by 97.77% in one year.
Market Cap
57.55M
Enterprise Value
-15.08M
1-Year Change
97.77%
Global Rank
Country Rank
#4,563 United States
Category
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $57.55M, a decrease of -83.83%. That is a compound annual growth rate of -51.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 57.55M | 114.25% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 62.21M |
| RenovoRx | 61.83M |
| Pliant Therapeutics | 61.30M |
| Kalaris Therapeutics | 60.70M |
| Eloxx Pharmaceuticals | 60.06M |
| Fractyl Health | 59.96M |
| Alterity Therapeutics | 59.88M |
| Connect Biopharma Holdings | 59.49M |